R&D Beyond proof of concept: Alzheimer’s and the next chapter of... Research has demonstrated that some individuals at elevated risk of Alzheimer's disease can be identified before symptoms emerge.
R&D Trajectory-based diagnostics enable early intervention in pr... Diagnostic testing in modern medicine remains largely episodic and threshold-based.
R&D Advancements in early detection and innovative therapies tar... Alzheimer’s disease (AD) robs millions of individuals of their memories, cognitive function, and independence, placing an immense emotional and financial burden on families and healthcare s
News CE marked certification for AI stroke software, Methinks Methinks announces CE marked certification of its medical imaging software for stroke.
News AstraZeneca, MSD raise prostate cancer awareness with 'Never... A new global prostate cancer awareness campaign developed by biopharmaceutical companies AstraZeneca (AZ) and Merck & Co.
News Remepy's hybrid Parkinson's therapy poised for phase 3 Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.